Arca Biopharma | ABIO - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 4.68B 65M 2026-09
Arca Biopharma USD -36.43M 2M 2026-03
Biogen USD 419.5M 663.3M 2026-09
Brainstorm Cell Therapeutics USD -2.05M 198K 2026-03
Bristol-Myers Squibb USD 255M 44M 2026-09
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cipla INR 10.43B 1.55B 2026-09
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 2.64B 1.97B 2025-12
Cytokinetics USD -167.09M 12.08M 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Laboratory Of America USD 418M 38.7M 2026-09
Myriad Genetics USD -3M 20.3M 2025-12
Otsuka Holdings JPY 142.24B 1.83B 2026-09
Pfizer USD 662M 5M 2026-09
United Therapeutics USD 241.3M 89.5M 2026-09